A new treatment strategy for locally advanced liver cancer, known as “reduce and remove,” was announced by the Department of Surgery and Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed) earlier this year. This innovative approach provides a way for patients with inoperable locally advanced liver cancer to be cured.
Unraveling the association between neonatal proteins and adult health
Research led by Professor John McGrath from the University of Queensland found that the concentration of the C4 protein, an important part of the immune system, was not associated with risk of mental disorders.
Researchers develop ‘potent and specific’ compounds to curb cancer growth
Proteasomes are protein-degrading complexes that are important for cancer cell survival. Proteasome inhibitors are commonly used to treat diseases such as multiple myeloma and mantle cell lymphoma. Proteasomes have three different active sites but all current FDA-approved inhibitors preferentially target only one active site, known as β5. Despite their success, these drugs have significant limitations including severe side effects and drug resistance.
New drug combinations raise hopes of effective, locally administered snakebite treatment
New drug combinations could protect snakebite victims from the devastating, life-changing injuries caused by toxic venom, suggests research led by Lancaster University.
New understanding of devastating type of breast cancer spread could lead to better treatments
A new study has increased the understanding of an increasingly common complication of advanced breast cancer. Using a novel approach, researchers have uncovered details of secondary breast cancer in the brain and spinal cord that may help with developing effective treatments for people whose disease progresses in this way.
Research reveals novel ways of cultivating brain cells to treat and study
Scientists from Duke-NUS Medical School and their collaborators have come up with new methods to cultivate brain cells from stem cells to treat and study neurodegenerative diseases. This novel technology forms the basis of two recent research projects under the newly established GK Goh Center for Neuroscience (the GK Goh Center) at Duke-NUS, offering hope for new treatments to patients suffering from neurological conditions such as Alzheimer’s disease, ischemic stroke and Parkinson’s Disease.
High cholesterol caused by childhood sedentariness could be reversed with light physical activity
Increased sedentary time in childhood can raise cholesterol levels by two thirds as an adult, leading to heart problems and even premature death—but a new study has found light physical activity may completely reverse the risks and is far more effective than moderate-to-vigorous physical activity.
Why people with diabetes are more prone to respiratory risk
For decades, it has been known that people with diabetes are at a substantially increased risk of developing severe lung disease if they become infected with viruses such as influenza, as well as with bacteria and fungi.
Moderna CEO says melanoma vaccine could be available by 2025
Moderna CEO Stephane Bancel told AFP his company’s experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.
Global research collaboration maps brain development in infancy and early childhood
The brains of infants and young children are in continuous and rapid development. These changes are known to go hand in hand with early life learning and the fine-tuning of mental abilities over time.